Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sebastian Schneeweiss
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Aetion, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Schneeweiss, a co-founder of Aetion, Inc., owns equity in the private company and receives cash compensation from the company for consulting services. The company develops a data analytics platform for evidence based health care decision-making. The projects will use Aetion software for data analysis. The results of the projects could help Aetion enhance and/or refine its data analytics platform. The Partners Committee on Outside Activities review panel evaluated the financial interest in connection with this research project and determined that, based on the close connection between the company's interests and the research, the financial interest could directly and significantly affect the design, conduct, or reporting of the research.
Randomized Cardiovascular Trials Duplicated Using Prospective Longitudinal Insurance Claims: Applying Techniques of Epidemiology (RCT DUPLICATE)
Project Narrative The proposed project provides fundamental knowledge on what types of clinical questions can be answered with real world data and with which methods. Findings will impact public health by improving the conduct of real world data studies and increasing confidence in their results, allowing for improved treatment decision- making even in the absence of randomized trial evidence.
Filed on April 01, 2019.
Tell us what you know about Sebastian Schneeweiss's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Sebastian Schneeweiss”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Sebastian Schneeweiss | Brigham and Women's Hospital | Conflict of Interest | Aetion, Inc. | $200,000 - $249,999 |
| Sebastian Schneeweiss | Brigham and Women's Hospital | Conflict of Interest | Aetion, Inc. | Value cannot be readily determined |
| Sebastian Schneeweiss | Brigham and Women's Hospital | Conflict of Interest | Aetion, Inc. | $200,000 - $249,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.